Home » Topics » Immuno-oncology, BioWorld Science

Immuno-oncology, BioWorld Science
RSS

ImClone, E. Merck continue cancer vaccine collaboration

May 24, 1996

Vical, Corixa to collaborate on immunotherapeutic drugs for cancer

May 24, 1996

Patent protection obtained for IDEC-C2B8

May 24, 1996

Genentech completes investment in IDEC ahead of schedule

May 17, 1996

U.S. NDA filed for bropirimine

May 17, 1996

Promising clinical data for GVAX reported at scientific meeting

May 17, 1996

Human Genome Sciences claims chemokine beta-9 polypeptides and their antagonists

May 17, 1996

Melacine NDA filing in sight

May 10, 1996

Jenner Technologies in-licenses MTP-PE from Ciba

May 10, 1996

Allovectin-7 clinical results announced at AACR

May 3, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...